Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Dermatology/Plastic Surgery | Oncology
Clinical Trials: Mycosis Fungoides
A listing of clinical trials currently looking for volunteers to enroll in Mycosis Fungoides studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : University of Alabama at Birmingham
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
California
Stanford : Stanford University School of Medicine
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Stanford : Stanford University Medical Center
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Louisiana
New Orleans : Tulane University Health Science Center
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
New Jersey
Hackensack : John Theurer Cancer Center (Hackensack University Medical Center)
A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell Lymphoma
New York
New York : New York Medical Center
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Ohio
Columbus : Ohio State University Medical Center
Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Pennsylvania
Philadelphia : University of Pennsylvania Health System
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Pittsburgh : University of Pittsburgh School of Medicine
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Texas
Houston : S. R. Burzynski Clinic
Phase II Study Of Antineoplaston A10 And AS2-1 In Patients With Mycosis Fungoides - Sezary Syndrome
View More »
Houston : MD Anderson Cancer Center
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Houston : UT MD Anderson Cancer Center
SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
Houston : MD Anderson Cancer Center
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Japan
Isehara : *
E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma
